Mirati Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 4.73, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Mirati Therapeutics Inc 's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 77 days, from 59 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 433 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 2864 to 2923.

What is Receivable Turnover Ratio?
What is Mirati Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRTX Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	201.97 %	155.32 %	910.86 %	212.37 %	-92.44 %
Receivable Turnover Ratio (TTM)	4.73	6.18	10.66	57.51	-
MRTX's Total Ranking	# 2923	# 2864	# 3713	# 2528	# 3713
Accounts Receivable average collection period days	77	59	34	6	-
Seq. Receivable Change	39.23 %	68.99 %	619.88 %	-	-
Seq. Revenue Change	19.8 %	91.01 %	667.34 %	-82.8 %	1.29 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 147
Healthcare Sector	# 434
Overall Market	# 2923

Receivable Turnover Ratio Statistics
High	Average	Low
57.51	19.77	4.73
(Dec 31 2022)		(Sep 30 2023)

MRTX Company Profile • Back to MRTX Efficiency Comparisons • Compare MRTX Receivables Turnover Ratio to its Competitors

Financial Statements
Mirati Therapeutics Inc 's Accounts Receivable	$ 15 Millions	Visit MRTX's Balance sheet
Mirati Therapeutics Inc 's Sales TTM	$ 38 Millions	Visit MRTX's Income Statement
Sources of MRTX's Revenues		Visit MRTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MRTX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MRTX's Growth Rates	MRTX's Roa	MRTX's Inventory Turnover Ratio	MRTX's Dividend Comparisons
MRTX's Profitability Ratios	MRTX's Roi	MRTX's Asset Turnover Ratio	MRTX's Dividend Growth
MRTX's Valuation Ratios	MRTX's Roe	MRTX's Financial Strength Ratios	MRTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Pediatrix Medical Group Inc	7.16	$ 2,012.041 Millions	$ 280.933 Millions
Stablecoin Development Corporation	7.15	$ 13.126 Millions	$ 1.837 Millions
Hca Healthcare Inc	7.13	$ 63,162.000 Millions	$ 8,860.750 Millions
Uphealth Inc	7.13	$ 151.772 Millions	$ 21.298 Millions
Elutia Inc	7.11	$ 41.536 Millions	$ 5.841 Millions
Pulmonx Corporation	7.10	$ 63.723 Millions	$ 8.970 Millions
Teleflex Incorporated	7.07	$ 2,958.062 Millions	$ 418.339 Millions
Embecta Corp	7.05	$ 1,119.900 Millions	$ 158.750 Millions
Inhibikase Therapeutics Inc	7.04	$ 0.324 Millions	$ 0.046 Millions
Sonendo Inc	7.04	$ 42.498 Millions	$ 6.034 Millions
Clever Leaves Holdings Inc	7.04	$ 16.260 Millions	$ 2.309 Millions
Ultragenyx Pharmaceutical Inc	7.04	$ 410.205 Millions	$ 58.305 Millions
Tela Bio Inc	7.02	$ 51.317 Millions	$ 7.310 Millions
Evolus Inc	7.01	$ 184.732 Millions	$ 26.341 Millions
Vanda Pharmaceuticals Inc	7.01	$ 211.851 Millions	$ 30.230 Millions
Lakeland Industries Inc	6.99	$ 122.446 Millions	$ 17.515 Millions
Akoya Biosciences Inc	6.97	$ 90.021 Millions	$ 12.909 Millions
Elite Pharmaceuticals Inc	6.96	$ 39.758 Millions	$ 5.712 Millions
Puma Biotechnology Inc	6.96	$ 229.134 Millions	$ 32.945 Millions
Ethema Health Corporation	6.95	$ 5.454 Millions	$ 0.785 Millions
Tenet Healthcare Corp	6.93	$ 20,159.000 Millions	$ 2,909.250 Millions
Sintx Technologies Inc	6.92	$ 2.490 Millions	$ 0.360 Millions
Adc Therapeutics Sa	6.92	$ 262.676 Millions	$ 37.985 Millions
3m Company	6.91	$ 32,747.000 Millions	$ 4,742.250 Millions
Alnylam Pharmaceuticals Inc	6.87	$ 1,723.609 Millions	$ 250.869 Millions
Pacira Biosciences inc	6.87	$ 665.689 Millions	$ 96.909 Millions
Aurinia Pharmaceuticals Inc	6.85	$ 158.853 Millions	$ 23.193 Millions
Select Medical Holdings Corp	6.85	$ 6,586.658 Millions	$ 961.871 Millions
Yunhong Green Cti Ltd	6.85	$ 15.155 Millions	$ 2.214 Millions
Axogen inc	6.82	$ 152.254 Millions	$ 22.325 Millions

Date modified: 2026-08-29T17:18:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.